Email
Print
Biologics And Biosimilars Market - Forecast(2024 - 2030)
1. Biologics And Biosimilars Market - Overview
1.1 Definitions and Scope
2. Biologics And Biosimilars Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biologics And Biosimilars Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biologics And Biosimilars Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biologics And Biosimilars Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biologics And Biosimilars Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biologics And Biosimilars Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biologics And Biosimilars Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Antibody
8.3.2 Hormone
8.3.3 Growth Factor
9. Biologics And Biosimilars Market - By Product (Market Size -$Million / $Billion)
10. Biologics And Biosimilars - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Tumor
10.3.2 Diabetes
10.3.3 Cardiovascular
10.3.4 Heamophilia
11. Biologics And Biosimilars- By Geography (Market Size -$Million / $Billion)
11.1 Biologics And Biosimilars Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biologics And Biosimilars- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biologics And Biosimilars- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biologics And Biosimilars - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biologics And Biosimilars - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biologics And Biosimilars Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biologics And Biosimilars Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biologics And Biosimilars Market - Key Company List by Country Premium
15. Biologics And Biosimilars Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazenca
15.3 Aurobindo Pharma Ltd
15.4 Concord Biotech
15.5 Glaxosmithkline Plc
15.6 H.Lundbeck A/S
15.7 Merck Co Inc
15.8 Novartis Global
15.9 Pfizer Inc
15.10 Retractable Technologies, Inc
15.11 Smith Medical
15.12 Company 11
15.13 Company 12 & More
16.1 Abbreviations
16.2 Sources
17. Biologics And Biosimilars Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Biologics And Biosimilars Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biologics And Biosimilars Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biologics And Biosimilars Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biologics And Biosimilars Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biologics And Biosimilars Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biologics And Biosimilars Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biologics And Biosimilars Market - By Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Antibody
8.3.2 Hormone
8.3.3 Growth Factor
9. Biologics And Biosimilars Market - By Product (Market Size -$Million / $Billion)
10. Biologics And Biosimilars - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Tumor
10.3.2 Diabetes
10.3.3 Cardiovascular
10.3.4 Heamophilia
11. Biologics And Biosimilars- By Geography (Market Size -$Million / $Billion)
11.1 Biologics And Biosimilars Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biologics And Biosimilars- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biologics And Biosimilars- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biologics And Biosimilars - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biologics And Biosimilars - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biologics And Biosimilars Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biologics And Biosimilars Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biologics And Biosimilars Market - Key Company List by Country Premium
15. Biologics And Biosimilars Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astrazenca
15.3 Aurobindo Pharma Ltd
15.4 Concord Biotech
15.5 Glaxosmithkline Plc
15.6 H.Lundbeck A/S
15.7 Merck Co Inc
15.8 Novartis Global
15.9 Pfizer Inc
15.10 Retractable Technologies, Inc
15.11 Smith Medical
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Biologics And Biosimilars Market - Appendix16.1 Abbreviations
16.2 Sources
17. Biologics And Biosimilars Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)1.1 Antibody Market 2023-2030 ($M) - Global Industry Research
1.2 Hormone Market 2023-2030 ($M) - Global Industry Research
1.3 Growth Factor Market 2023-2030 ($M) - Global Industry Research
2.Global Biologics And Biosimilars Market, By Type Market 2023-2030 (Volume/Units)
2.1 Antibody Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Hormone Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Growth Factor Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)
3.1 Antibody Market 2023-2030 ($M) - Regional Industry Research
3.2 Hormone Market 2023-2030 ($M) - Regional Industry Research
3.3 Growth Factor Market 2023-2030 ($M) - Regional Industry Research
4.South America Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)
4.1 Antibody Market 2023-2030 ($M) - Regional Industry Research
4.2 Hormone Market 2023-2030 ($M) - Regional Industry Research
4.3 Growth Factor Market 2023-2030 ($M) - Regional Industry Research
5.Europe Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)
5.1 Antibody Market 2023-2030 ($M) - Regional Industry Research
5.2 Hormone Market 2023-2030 ($M) - Regional Industry Research
5.3 Growth Factor Market 2023-2030 ($M) - Regional Industry Research
6.APAC Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)
6.1 Antibody Market 2023-2030 ($M) - Regional Industry Research
6.2 Hormone Market 2023-2030 ($M) - Regional Industry Research
6.3 Growth Factor Market 2023-2030 ($M) - Regional Industry Research
7.MENA Biologics And Biosimilars Market, By Type Market 2023-2030 ($M)
7.1 Antibody Market 2023-2030 ($M) - Regional Industry Research
7.2 Hormone Market 2023-2030 ($M) - Regional Industry Research
7.3 Growth Factor Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Biologics And Biosimilars Market Revenue, 2023-2030 ($M)2.Canada Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
3.Mexico Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
4.Brazil Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
5.Argentina Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
6.Peru Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
7.Colombia Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
8.Chile Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
9.Rest of South America Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
10.UK Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
11.Germany Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
12.France Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
13.Italy Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
14.Spain Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
15.Rest of Europe Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
16.China Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
17.India Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
18.Japan Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
19.South Korea Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
20.South Africa Biologics And Biosimilars Market Revenue, 2023-2030 ($M)
21.North America Biologics And Biosimilars By Application
22.South America Biologics And Biosimilars By Application
23.Europe Biologics And Biosimilars By Application
24.APAC Biologics And Biosimilars By Application
25.MENA Biologics And Biosimilars By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Astrazenca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis Global, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Merck Co Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Smith Medical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Concord Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Aurobindo Pharma Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.H.Lundbeck A/S, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Retractable Technologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)